feed,title,long_url,short_url
Benzinga,SVB Leerink Sees Over 600% Upside For This Penny Biotech Stock,https://benzinga.com/analyst-ratings/analyst-color/22/06/27573199/svb-leerink-sees-over-600-upside-for-this-penny-biotech-stock,https://bit.ly/3GSFCLp
Benzinga,Regulatory Update On Intercept Pharma's Obeticholic Acid For NASH Delayed Again,https://benzinga.com/analyst-ratings/analyst-color/22/06/27572457/regulatory-update-on-intercept-pharmas-obeticholic-acid-for-nash-delayed-again,https://bit.ly/3GY1VPW
